GALT — Galectin Therapeutics Inc.

GALTGalectin Therapeutics Inc.

NAS · US · Healthcare · Biotechnology · galectintherapeutics.com

2.620USD+3.97%Mkt Cap: 171.23M USDP/E: —Last update: 2026-06-01

Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in drug development to create new therapies for fibrotic disease and cancer. The company's lead product candidate is belapectin (GR-MD-02), …

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

40.10BUSDP/E 75.3

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap171.23M USD

Enterprise Value292.75M USD

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-30.84M USD

Revenue/Share—

Last Price2.620 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees9

CountryUS

SectorHealthcare

IndustryBiotechnology

ISINUS3632252025

Valuation

P/E (Trailing)—

P/E (Forward)-1.50

PEG-36.15

EV/EBITDA—

EV/Revenue—

P/S—

P/B-1.25

EPS (TTM)-0.41

EPS (Forward)-1.68

52W Range

1.25023% of range7.130

52W High7.130 USD

52W Low1.250 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE24.44%

ROA-157.87%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-23.88M USD

CapEx (TTM)—

FCF Margin—

FCF Yield-10.90%

Net Debt124.58M USD

Net Debt/EBITDA—

Balance Sheet

Debt/Equity-1.06

Current Ratio2.15

Quick Ratio1.93

Book Value/Sh-2.0110 USD

Cash/Share0.2140 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:6

Split DateMar 23, 2012

Analyst Consensus

Rating1.0 (Strong Buy)

Target (Mean)11.00 USD

Target Range11.00 USD – 11.00 USD

# Analysts1

Ownership

Shares Out.65.86M

Float47.19M

Insiders29.09%

Institutions21.17%

Short Interest

Short Ratio22.7d

Short % Float17.53%

Short % Out.11.18%

Shares Short7.36M

Short (prev mo.)7.46M

Technical

SMA 502.438 (+7.4%)

SMA 2003.854 (-32.0%)

Beta0.45

S&P 52W Chg27.94%

Avg Vol (30d)315.38K

Avg Vol (10d)383.89K

Technical Indicators

RSI (14)54.2

MACD0.0489

MACD Signal-0.0077

MACD Hist.+0.0566

BB Upper2.728 USD

BB Middle2.326 USD

BB Lower1.925 USD

BB Width34.52%

ATR (14)0.2046 USD

Vol Ratio (20d)0.62x